Roche (RHHBY) unveiled its proprietary, breakthrough sequencing by expansion technology, establishing a new category of next-generation ...

Roche has put forward a new approach to genetic analysis, which it describes as sequencing-by-expansion—a proprietary method that pulls apart the DNA molecule and amplifies the signal of | Roche said ...

The "Global Cardiac Biomarkers Diagnostics Industry, 2024-2029" report has been added to ResearchAndMarkets.com's offering. This research service provides an overview of the global cardiac biomarkers ...

This report describes and explains the liquid biopsy for cancer diagnostics market and covers 2019-2024, termed the historic ...

Like Bio-Hermes-001, the Bio-Hermes-002 study is paving the way for improving participation by trial participants who are traditionally underrepresented in Alzheimer’s clinical research, with an ...

After a general alignment of the company’s structures, Roche was left with four core business sectors – pharmaceuticals, vitamins and fine chemicals, diagnostics, and flavours and fragrances.

Long-serving Roche chief executive Severin Schwan is stepping down, to be replaced next March by Thomas Schinecker, currently head of diagnostics at the Swiss group. Schwan (pictured above ...

The PCR-based point-of-care assays, which return results within 20 minutes, have received regulatory approval from the US Food and Drug Administration earlier this year.

The Canadian Generic Pharmaceutical Association (CGPA) is pleased to announce the unanimous election of Michel Robidoux, ...

Has drug giant Roche finally cracked DNA sequencing? The company has claimed it can decode the genome in as little as four ...

The dynamics of the multiple system atrophy treatment market is anticipated to change during the forecast period as companies across the 7MM are diligently working towards the development of novel ...